Northland Capmk Has Negative Outlook for inTEST Q2 Earnings

inTEST Co. (NYSE:INTT) – Equities researchers at Northland Capmk reduced their Q2 2025 earnings per share (EPS) estimates for shares of inTEST in a note issued to investors on Monday, May 5th. Northland Capmk analyst E. Jackson now forecasts that the company will post earnings of ($0.04) per share for the quarter, down from their previous estimate of $0.09. Northland Capmk currently has a “Hold” rating on the stock. The consensus estimate for inTEST’s current full-year earnings is $0.41 per share. Northland Capmk also issued estimates for inTEST’s Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.08 EPS, FY2025 earnings at ($0.09) EPS, Q1 2026 earnings at ($0.08) EPS, Q2 2026 earnings at ($0.01) EPS, Q3 2026 earnings at $0.01 EPS, Q4 2026 earnings at $0.10 EPS, FY2026 earnings at $0.02 EPS, FY2027 earnings at $0.17 EPS and FY2028 earnings at $0.28 EPS.

inTEST (NYSE:INTT) last posted its quarterly earnings data on Friday, May 2nd. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). inTEST had a net margin of 2.33% and a return on equity of 5.31%. During the same quarter in the previous year, the business posted $0.10 earnings per share.

Separately, Lake Street Capital cut their target price on shares of inTEST from $10.00 to $8.00 and set a “buy” rating on the stock in a research note on Monday, May 5th.

inTEST Trading Down 4.8 %

INTT opened at $6.10 on Thursday. The business has a fifty day moving average price of $6.66 and a 200 day moving average price of $7.64. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.26 and a quick ratio of 1.38. inTEST has a 12 month low of $5.24 and a 12 month high of $11.92. The stock has a market capitalization of $76.22 million, a price-to-earnings ratio of 26.52 and a beta of 1.63.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of INTT. Royce & Associates LP lifted its position in inTEST by 17.5% during the 4th quarter. Royce & Associates LP now owns 1,433,099 shares of the company’s stock worth $12,310,000 after acquiring an additional 213,942 shares during the period. Ameriprise Financial Inc. grew its position in inTEST by 43.2% in the 4th quarter. Ameriprise Financial Inc. now owns 493,524 shares of the company’s stock valued at $4,239,000 after buying an additional 148,784 shares during the last quarter. Pacific Ridge Capital Partners LLC increased its stake in inTEST by 6.6% in the 4th quarter. Pacific Ridge Capital Partners LLC now owns 582,483 shares of the company’s stock valued at $5,004,000 after buying an additional 36,031 shares during the period. Russell Investments Group Ltd. raised its position in inTEST by 208.9% during the 4th quarter. Russell Investments Group Ltd. now owns 43,543 shares of the company’s stock worth $374,000 after buying an additional 29,445 shares during the last quarter. Finally, First Eagle Investment Management LLC lifted its stake in shares of inTEST by 2.9% in the 4th quarter. First Eagle Investment Management LLC now owns 602,608 shares of the company’s stock worth $5,176,000 after acquiring an additional 16,744 shares during the period. 63.18% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at inTEST

In other inTEST news, Director Gerald J. Maginnis bought 7,557 shares of the business’s stock in a transaction dated Tuesday, May 6th. The shares were acquired at an average cost of $5.78 per share, with a total value of $43,679.46. Following the acquisition, the director now directly owns 78,057 shares of the company’s stock, valued at $451,169.46. The trade was a 10.72 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 5.50% of the company’s stock.

About inTEST

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.